RSS
16 Jan 2023

KAZIA RAISES A$4.5 MILLION TO PROGRESS R&D PROGRAMS

Author: admintech | Filed under: Press Release

SYDNEY, Jan. 16, 2023 /PRNewswire/ — Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce a placement of KZA shares, to institutional and sophisticated investors in Australia, at a price of A$0.11 per share. The…

This entry was posted on Monday, January 16th, 2023 at 7:11 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»